Proteros
proteros.com
Actively hiring
CRO & CDMO Services
Drug Discovery
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
How Proteros hires
Truth index
D 52/100
Ghost roles
80%
Stale roles
0%
Reposted roles
0%
Proteros scores D on the Alion truth index (A is best, E worst), measured over 10 open roles re-checked against its own hiring board: 80% look like ghost listings, 0% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
News
Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library ...
Read more
Report
Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases
Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engineProteros to support Adrestia in the discovery of first-in-class drugs for intractable genetic diseasesSignals new phase for Adrestia's portfolio of validated synthetic
Read more
Report
Proteros Enters Into Oncology Collaboration and License Agreement With AstraZeneca
--Proteros to receive research funding and milestone payments plus royalties-- Proteros biostructures GmbH ("Proteros") today announced that it has signed an agreement with AstraZeneca (LSE/STO/Nasdaq:
Read more
Report
Proteros Enters Into Oncology Collaboration and License Agreement With AstraZeneca
Proteros biostructures GmbH today announced that it has signed an agreement with AstraZeneca to jointly discover and develop novel small molecules for the potential treatment of various types of cancer. "We believe that advances in epigenomic capabilities
Read more
Report
Proteros launches new cryo-EM facility to speed drug discovery
/PRNewswire/ -- The new Center of Excellence will focus on technologically challenging targets, building on Proteros
Read more
Report
Proteros launches new cryo-EM facility to speed drug discovery
/CNW/ -- The new Center of Excellence will focus on technologically challenging targets, building on Proteros
Read more
Report
Proteros, co-founder of Rodin Therapeutics, announces Rodin
MUNICH, GERMANY / ACCESSWIRE / November 28, 2019 / Proteros biostructures GmbH today announced that Rodin Therapeutics, Inc., a Boston, MA based biotech company developing novel, small molecule therapeutics ...
Read more
Report
Proteros Enters into New Research Collaboration with Johnson & Johnson Innovation on Sub-Class of Epigenetic Targets
Read more
Report
Growth
Hiring Momentum
41/100
Stable
Open positions
10
0 opened / 3 closed in 30 days
Median time-to-fill
328 days
faster than 6% of the market
ATS activity
Every ~1 days
10/16/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
50% ▼
Sales
50% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Munich
Munich
Germany
Regional office
10 open roles 2 posted in 90 days 60% engineering 50-200 est. staff
hires for Science & Research, Administrative, Management